CLASS II Drug recall · Reported 2 May 2018 · FDA Enforcement Report
Ibuprofen Tablets USP 800 mg, a) recalled by Time-Cap Laboratories
Time-Cap Laboratories is recalling Ibuprofen Tablets USP 800 mg, a) (, distributed nationwide in the US. The recall was initiated on 11 Jan 2018 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0693-2018
- FDA event ID
- 79349
- Recalling firm
- Time-Cap Laboratories, Farmingdale, NY
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 11 Jan 2018
- FDA classified
- 22 Apr 2018
- Reported
- 2 May 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Pain Medication
Timeline
| 11 Jan 2018 | Recall initiated by company | |
| 22 Apr 2018 | Classified by FDA | +101 days |
| 2 May 2018 | Published in enforcement report | +10 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Product as listed by the FDA
Ibuprofen Tablets USP 800 mg, a) 100 tablet (NDC 42582-113-10) and b) 500 tablet (NDC 42582-113-18) bottles, Rx, Distributed by; Bi-Coastal Pharma International, Shrewsbury, NJ, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India
Where it was distributed
Nationwide.
Questions about this recall
Is Ibuprofen Tablets USP 800 mg, a) ( recalled?
Yes. Time-Cap Laboratories recalled Ibuprofen Tablets USP 800 mg, a) ( on 11 Jan 2018. The recall is Class II and its status is Terminated. Recall number D-0693-2018.
Why was it recalled?
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Which lots are affected?
a) C140C, exp 2/18; b) D049C, D050C, D051C, C142C, C137C, C138C, C141C, exp 2/18; D073C, D074C, exp 3/18
Where was it sold?
Nationwide.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Time-Cap Laboratories
All 12| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ibuprofen Caplets USP 200 mg, a) 50 caplets recalledIbuprofen | Time-Cap Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Ibuprofen Tablets, USP, 200 mg, a) recalled by Time-Cap LaboratoriesIbuprofen | Time-Cap Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Ibuprofen Tablets USP 400 mg bottles recalled by Time-Cap Laboratories | Time-Cap Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Ibuprofen Caplets USP 200 mg, a) 50 caplets recalledIbuprofen | Time-Cap Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Ibuprofen Tablets, USP, 200 mg, a) recalled by Time-Cap LaboratoriesIbuprofen | Time-Cap Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
Other Ibuprofen recalls
All 38| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Children's Ibuprofen Oral Suspension, USP, 100 mg recalledIbuprofen | Strides Pharma | Particulate Matter | Nationwide |
| Drug | CLASS III | IBU (ibuprofen) recalled by Dr. Reddy's LaboratoriesIbu | Dr. Reddy's Laboratories | Other | Nationwide |
| Drug | CLASS II | IBU Ibuprofen Tablets, USP, 600 mg recalled by Dr. Reddy's LaboratoriesIbu | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | IBU Ibuprofen Tablets, USP, 400 mg recalled by Dr. Reddy's LaboratoriesIbu | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size recalled | Preferred Pharmaceuticals | Potency & Assay | CA, NV |